Raymond James analyst Christopher Raymond reiterated a Strong Buy rating and $34.00 price target on Climb Bio (NASDAQ: CLYM).The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE